Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

Item
http://www.wikidata.org/entity/Q38892533
Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A ReviewTargeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future PerspectivesA review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.Growth inhibition effect of HMME-mediated PDT on hepatocellular carcinoma HepG2 cells.Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumourHypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy.Does St. John's Wort cause regression in gastrointestinal system adenocarcinomas?Hypericin-photodynamic therapy induces human umbilical vein endothelial cell apoptosisCytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.Photodynamic therapy as a new treatment modality for inflammatory and infectious conditions.Natural extracellular nanovesicles and photodynamic molecules: is there a future for drug delivery?Analysis of Hypericin-Mediated Effects and Implications for Targeted Photodynamic Therapy.Mangiferin: A xanthonoid with multipotent anti-inflammatory potential.Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes.Hypericin-photodynamic therapy inhibits proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes cell line MH7A.
P2860

Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

Item
http://www.wikidata.org/entity/Q38892533
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Hypericin-photodynamic therapy ...... in death agonist and caspases.
@en
type
label
Hypericin-photodynamic therapy ...... in death agonist and caspases.
@en
prefLabel
Hypericin-photodynamic therapy ...... in death agonist and caspases.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Hypericin-photodynamic therapy ...... in death agonist and caspases.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932